focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.115
Bid: 0.11
Ask: 0.12
Change: 0.00 (0.00%)
Spread: 0.01 (9.091%)
Open: 0.115
High: 0.115
Low: 0.115
Prev. Close: 0.115
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

28 Jul 2017 11:10

RNS Number : 4378M
Deltex Medical Group PLC
28 July 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

DELTEX MEDICAL GROUP PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: MISSED DISCLOSURE DUE TO SHARES IN ISSUE CHANGE

3. Details of person subject to the notification obligationiv

Name

J O HAMBRO CAPITAL MANAGEMENT LIMITED

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

27 JULY 2017

6. Date on which issuer notified (DD/MM/YYYY):

28 JULY 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

9.72%

0.00%

9.72%

313,115,807

Position of previous notification (if

applicable)

10.68%

0.00%

10.68%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0059337583

30,419,696

9.72%

SUBTOTAL 8. A

30,419,696

9.72%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

-

The number and % of voting rights held

-

The date until which the voting rights will be held

-

11. Additional informationxvi

.

 

 

Place of completion

J O HAMBRO CAPITAL MANAGEMENT, LONDON

Date of completion

28 JULY 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEAEXPAELXEFF
Date   Source Headline
18th Apr 20087:00 amRNSCompletion of Funding Package
15th Apr 20087:01 amRNSCardioQ update
14th Apr 20087:01 amRNSCardioQ update
7th Apr 20087:01 amRNSFinal Results
7th Apr 20087:01 amRNSNew Non-Executive Director
3rd Apr 20087:00 amRNSCardioQ update
2nd Apr 20087:01 amRNSCardioQ update
28th Mar 20087:02 amRNSNTAH update
26th Mar 20087:02 amRNSCardioQ update
20th Mar 20087:00 amRNSNotice of Results
3rd Mar 20083:22 pmRNSODM meta - analysis
25th Jan 20083:58 pmRNSDirector/PDMR Shareholding
23rd Jan 20087:01 amRNSPositive Scientific Review
23rd Jan 20087:01 amRNSPre-close update
18th Jan 200811:41 amRNSHSJ Article
26th Nov 20079:03 amRNSDirector/PDMR Shareholding
21st Nov 20077:02 amRNSCardioQ Product Endorsement
31st Oct 20072:15 pmRNSTotal Voting Rights
22nd Oct 20079:01 amRNSHolding(s) in Company
16th Oct 20074:03 pmRNSAdditional Listing
1st Oct 20077:06 amRNSCardioQ announcement
25th Sep 200711:00 amRNSInterim Results - Replacement
25th Sep 20077:03 amRNSInterim Results
16th Aug 20073:53 pmRNSAIM Rule 26 Information
31st Jul 20073:29 pmRNSTotal Voting Rights
25th Jul 200711:30 amRNSRecommendation for CardioQ
11th Jul 20077:01 amRNSTrading Statement
5th Jul 20073:30 pmRNSImproving Surgical Outcomes
29th Jun 20073:34 pmRNSDirector/PDMR Shareholding
29th Jun 20073:26 pmRNSAdditional Listing
29th Jun 20078:52 amRNSTotal Voting Rights
28th Jun 20077:04 amRNSNew Clinical Evidence
22nd Jun 20077:01 amRNSAdditional Listing
19th Jun 20073:02 pmRNSHolding(s) in Company
14th Jun 20074:02 pmRNSAdditional Listing
7th Jun 20077:03 amRNSNew CardioQ Data
5th Jun 20077:02 amRNSUS Reimbursement Update
31st May 20078:49 amRNSTotal Voting Rights
23rd May 20077:32 amRNSUS Reimbursement Coverage
22nd May 20078:31 amRNSAdditional Listing
3rd May 20071:06 pmRNSIssue of Equity
3rd May 200710:25 amRNSAGM Statement
12th Apr 20077:01 amRNSUCLH adopts CardioQ
28th Mar 20078:00 amRNSHealth Technology Assessment
21st Mar 20072:53 pmRNSHolding(s) in Company
15th Mar 20077:05 amRNSUS Government HTA Published
15th Mar 20077:01 amRNSFinal Results
9th Mar 200712:35 pmRNSHolding(s) in Company
2nd Mar 20073:56 pmRNSDeltex SupraQ Demo Invite
28th Feb 20075:20 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.